Status:
RECRUITING
Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC
Lead Sponsor:
Henry Ford Health System
Conditions:
HIPEC
Eligibility:
All Genders
18+ years
Brief Summary
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a well-established alternative for patients with peritoneal surface malignancies. Although HIPEC has a predetermined protocol to manage body temper...
Detailed Description
Peritoneal surface malignancies are a group of cancers arising from rare primary or common secondary tumors. Regardless of the etiology, the prognosis is poor and only a few therapies have shown promi...
Eligibility Criteria
Inclusion
- Adults (at least 18 years or older)
- Scheduled to undergo HIPEC surgery for abdominal cancer at HFH-Main
Exclusion
- Pregnant females
- Minors
- Disease not amenable for treatment with HIPEC after surgical examination.
Key Trial Info
Start Date :
September 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05426928
Start Date
September 22 2022
End Date
March 31 2027
Last Update
October 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Katherine Nowak
Detroit, Michigan, United States, 48202